Hunter Shkolnik Comments on Proposed Opioid Settlement
December 5, 2019
Source: Daily Stock Dish
Teva Pharmaceutical Industries Ltd.’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts.
The deal is “overvalued to make the settlement look better,” said Hunter Shkolnik, a lawyer on the plaintiffs executive committee that is managing more than 2,300 federal lawsuits consolidated in the U.S. District Court in Cleveland.
“I don’t believe a no-cash payment from Teva, one of the largest generic manufacturers in the world, is appropriate,” he told Reuters.
Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson & Johnson and the three largest U.S. drug distributors, AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp.
Download
Featured Attorneys
Related Articles
Tax Payers First on the Hook for Space Crash
August 9, 2016
Another Challenger Catastrophe should never happen again. Yet, on Sunday, June 28th 2015, a SpaceX Falcon-9 rocket exploded after launching from Cape Canaveral Air Force Station, Florida during a resupply mission to the International Space Station. Debris from the explosion fell harmlessly into the Atlantic Ocean. But what if it didn’t? What if the debris fell in…Read the article
What Is Postpartum Depression?
December 4, 2017
Postpartum depression (PPD), also known as postnatal depression, is a condition that is characterized by feelings of depression and depression-related symptoms following childbirth. The mood disorder can make it difficult for new mothers to manage the day-to-day tasks of life, including caring for a newborn. Symptoms of Postpartum Depression The symptoms of postpartum depression are broad…Read the article